CVM CIK: 725363

CEL-SCI Corporation

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
45.3
FY22:
25.4
FY23:
6.92
FY24:
6.06
FY25:
11.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.6
FY22:
25.1
FY23:
23.6
FY24:
20.9
FY25:
16.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
75.9
FY22:
50.5
FY23:
30.5
FY24:
27.0
FY25:
28.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.94
FY22:
4.66
FY23:
5.59
FY24:
4.62
FY25:
5.13
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.4
FY22:
13.7
FY23:
11.7
FY24:
9.51
FY25:
7.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
56.5
FY22:
32.2
FY23:
13.2
FY24:
12.9
FY25:
16.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
75.9
FY22:
50.5
FY23:
30.5
FY24:
27.0
FY25:
28.2

All amounts in millions USD Data source:SEC EDGAR